179 related articles for article (PubMed ID: 25873590)
21. Systematic identification of genes with a cancer-testis expression pattern in 19 cancer types.
Wang C; Gu Y; Zhang K; Xie K; Zhu M; Dai N; Jiang Y; Guo X; Liu M; Dai J; Wu L; Jin G; Ma H; Jiang T; Yin R; Xia Y; Liu L; Wang S; Shen B; Huo R; Wang Q; Xu L; Yang L; Huang X; Shen H; Sha J; Hu Z
Nat Commun; 2016 Jan; 7():10499. PubMed ID: 26813108
[TBL] [Abstract][Full Text] [Related]
22. Identification of cancer fusion drivers using network fusion centrality.
Wu CC; Kannan K; Lin S; Yen L; Milosavljevic A
Bioinformatics; 2013 May; 29(9):1174-81. PubMed ID: 23505294
[TBL] [Abstract][Full Text] [Related]
23. Personalized characterization of diseases using sample-specific networks.
Liu X; Wang Y; Ji H; Aihara K; Chen L
Nucleic Acids Res; 2016 Dec; 44(22):e164. PubMed ID: 27596597
[TBL] [Abstract][Full Text] [Related]
24. The Discovery of Mutated Driver Pathways in Cancer: Models and Algorithms.
Zhang J; Zhang S
IEEE/ACM Trans Comput Biol Bioinform; 2018; 15(3):988-998. PubMed ID: 28113329
[TBL] [Abstract][Full Text] [Related]
25. A network-based analysis of colon cancer splicing changes reveals a tumorigenesis-favoring regulatory pathway emanating from ELK1.
Hollander D; Donyo M; Atias N; Mekahel K; Melamed Z; Yannai S; Lev-Maor G; Shilo A; Schwartz S; Barshack I; Sharan R; Ast G
Genome Res; 2016 Apr; 26(4):541-53. PubMed ID: 26860615
[TBL] [Abstract][Full Text] [Related]
26. Identification of candidate cancer drivers by integrative Epi-DNA and Gene Expression (iEDGE) data analysis.
Li A; Chapuy B; Varelas X; Sebastiani P; Monti S
Sci Rep; 2019 Nov; 9(1):16904. PubMed ID: 31729402
[TBL] [Abstract][Full Text] [Related]
27. CBNA: A control theory based method for identifying coding and non-coding cancer drivers.
Pham VVH; Liu L; Bracken CP; Goodall GJ; Long Q; Li J; Le TD
PLoS Comput Biol; 2019 Dec; 15(12):e1007538. PubMed ID: 31790386
[TBL] [Abstract][Full Text] [Related]
28. Compensatory relationship between splice sites and exonic splicing signals depending on the length of vertebrate introns.
Dewey CN; Rogozin IB; Koonin EV
BMC Genomics; 2006 Dec; 7():311. PubMed ID: 17156453
[TBL] [Abstract][Full Text] [Related]
29. Why Selection Might Be Stronger When Populations Are Small: Intron Size and Density Predict within and between-Species Usage of Exonic Splice Associated cis-Motifs.
Wu X; Hurst LD
Mol Biol Evol; 2015 Jul; 32(7):1847-61. PubMed ID: 25771198
[TBL] [Abstract][Full Text] [Related]
30. Computational analysis of splicing errors and mutations in human transcripts.
Kurmangaliyev YZ; Gelfand MS
BMC Genomics; 2008 Jan; 9():13. PubMed ID: 18194514
[TBL] [Abstract][Full Text] [Related]
31. Biased codon usage near intron-exon junctions: selection on splicing enhancers, splice-site recognition or something else?
Chamary JV; Hurst LD
Trends Genet; 2005 May; 21(5):256-9. PubMed ID: 15851058
[TBL] [Abstract][Full Text] [Related]
32. Mutational landscape of RNA-binding proteins in human cancers.
Neelamraju Y; Gonzalez-Perez A; Bhat-Nakshatri P; Nakshatri H; Janga SC
RNA Biol; 2018 Jan; 15(1):115-129. PubMed ID: 29023197
[TBL] [Abstract][Full Text] [Related]
33. Identifying core gene modules in glioblastoma based on multilayer factor-mediated dysfunctional regulatory networks through integrating multi-dimensional genomic data.
Ping Y; Deng Y; Wang L; Zhang H; Zhang Y; Xu C; Zhao H; Fan H; Yu F; Xiao Y; Li X
Nucleic Acids Res; 2015 Feb; 43(4):1997-2007. PubMed ID: 25653168
[TBL] [Abstract][Full Text] [Related]
34. Aberrant RNA splicing in cancer; expression changes and driver mutations of splicing factor genes.
Sveen A; Kilpinen S; Ruusulehto A; Lothe RA; Skotheim RI
Oncogene; 2016 May; 35(19):2413-27. PubMed ID: 26300000
[TBL] [Abstract][Full Text] [Related]
35. Whole-exome sequencing reveals recurrent somatic mutation networks in cancer.
Liu X; Wang J; Chen L
Cancer Lett; 2013 Nov; 340(2):270-6. PubMed ID: 23153794
[TBL] [Abstract][Full Text] [Related]
36. A pan-cancer atlas of cancer hallmark-associated candidate driver lncRNAs.
Deng Y; Luo S; Zhang X; Zou C; Yuan H; Liao G; Xu L; Deng C; Lan Y; Zhao T; Gao X; Xiao Y; Li X
Mol Oncol; 2018 Nov; 12(11):1980-2005. PubMed ID: 30216655
[TBL] [Abstract][Full Text] [Related]
37. A computational method for clinically relevant cancer stratification and driver mutation module discovery using personal genomics profiles.
Wang L; Li F; Sheng J; Wong ST
BMC Genomics; 2015; 16 Suppl 7(Suppl 7):S6. PubMed ID: 26099165
[TBL] [Abstract][Full Text] [Related]
38. How the evolution of multicellularity set the stage for cancer.
Trigos AS; Pearson RB; Papenfuss AT; Goode DL
Br J Cancer; 2018 Jan; 118(2):145-152. PubMed ID: 29337961
[TBL] [Abstract][Full Text] [Related]
39. DriverDBv2: a database for human cancer driver gene research.
Chung IF; Chen CY; Su SC; Li CY; Wu KJ; Wang HW; Cheng WC
Nucleic Acids Res; 2016 Jan; 44(D1):D975-9. PubMed ID: 26635391
[TBL] [Abstract][Full Text] [Related]
40. Splice site proximity influences alternative exon definition.
Carranza F; Shenasa H; Hertel KJ
RNA Biol; 2022 Jan; 19(1):829-840. PubMed ID: 35723015
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
